Showing 19,661 - 19,680 results of 31,017 for search '(( significant ((changes decrease) OR (change increases)) ) OR ( significant decrease decrease ))', query time: 0.68s Refine Results
  1. 19661

    Data Sheet 1_Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus.docx by Haoyi Yang (8215116)

    Published 2025
    “…Compared with those in the placebo group, the levels of several bile acids were significantly greater in the SY-009-treated groups. Moreover, the proportion of free bile acids decreased significantly, the proportion of glycine-conjugated bile acids increased significantly, the proportion of taurine-conjugated bile acids tended to be stable, and PBA/SBA significantly increased after SY-009 administration.…”
  2. 19662

    <b>ART does not correct plasma virome and cytokine dysregulations induced by HIV-1</b> by Yingying Ma (18762652)

    Published 2024
    “…Notably, most cytokines dysregulated were not fully restored by ART, with abnormal levels of IL-10, GM-CSF, VEGF, and eotaxin, and a significantly increased level of plasma I-FABP. Anelloviruses showed significantly negative correlations with other commensal viruses except HPgV-1, but had positive corrections with several anti-inflammatory and Th1 cytokines.…”
  3. 19663

    Supplementary file 2_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  4. 19664

    Supplementary file 5_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  5. 19665

    Supplementary file 3_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  6. 19666

    Supplementary file 1_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  7. 19667

    Supplementary file 4_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  8. 19668

    Image 1_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.pdf by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  9. 19669

    Image 2_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.pdf by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  10. 19670

    Supplementary file 6_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

    Published 2025
    “…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …”
  11. 19671

    Temporal Regulation of Myopia and Inflammation-Associated Pathways in the Interphotoreceptor Retinoid-Binding Protein Knockout Mouse Model by Shanu Markand (19730205)

    Published 2024
    “…Compared with WT, immunoblotting analysis of C1qa showed no significant differences at P5 but significantly increased protein levels at P7 in IRBP KOs. …”
  12. 19672

    Secondary and tertiary outcomes. by Maram Khaled (14642937)

    Published 2024
    “…Primary outcome is pain intensity with movement (elicited by asking the patient to move from supine to sitting position) using 0–10 Numerical Rating Scale (0 = no pain, 10 = worst possible pain).</p><p>Significance</p><p>The results of this study may result in improved pain control, maternal satisfaction and wound healing; decrease the use of perioperative opioids; potentially decrease the incidence of postpartum depression and persistent pain; and overall lead to better postoperative outcomes thereby decreasing healthcare costs.…”
  13. 19673

    CONSORT flow diagram. by Maram Khaled (14642937)

    Published 2024
    “…Primary outcome is pain intensity with movement (elicited by asking the patient to move from supine to sitting position) using 0–10 Numerical Rating Scale (0 = no pain, 10 = worst possible pain).</p><p>Significance</p><p>The results of this study may result in improved pain control, maternal satisfaction and wound healing; decrease the use of perioperative opioids; potentially decrease the incidence of postpartum depression and persistent pain; and overall lead to better postoperative outcomes thereby decreasing healthcare costs.…”
  14. 19674

    Data_ALL by Myriam Campos Aguilar (15856298)

    Published 2025
    “…<p dir="ltr">Metabolic syndrome (MetS) is a clinical condition characterized by multiple risk Q8 factors that significantly increase the likelihood of developing cardiovascular diseases and type 2 diabetes. …”
  15. 19675

    Image 3_Assessment of the brain impact of soccer heading using pupillary light reflex.tif by Junzo Nakao (21429026)

    Published 2025
    “…In session 2, only CH significantly decreased compared with the baseline. CH significantly decreases from the 20th heading onwards in session 1 compared with session 2 (both at 20 and 30 headings; p < 0.001). …”
  16. 19676

    Table 1_Assessment of the brain impact of soccer heading using pupillary light reflex.docx by Junzo Nakao (21429026)

    Published 2025
    “…In session 2, only CH significantly decreased compared with the baseline. CH significantly decreases from the 20th heading onwards in session 1 compared with session 2 (both at 20 and 30 headings; p < 0.001). …”
  17. 19677

    Image 2_Assessment of the brain impact of soccer heading using pupillary light reflex.tif by Junzo Nakao (21429026)

    Published 2025
    “…In session 2, only CH significantly decreased compared with the baseline. CH significantly decreases from the 20th heading onwards in session 1 compared with session 2 (both at 20 and 30 headings; p < 0.001). …”
  18. 19678

    Image 1_Assessment of the brain impact of soccer heading using pupillary light reflex.tif by Junzo Nakao (21429026)

    Published 2025
    “…In session 2, only CH significantly decreased compared with the baseline. CH significantly decreases from the 20th heading onwards in session 1 compared with session 2 (both at 20 and 30 headings; p < 0.001). …”
  19. 19679

    Image 4_Assessment of the brain impact of soccer heading using pupillary light reflex.tif by Junzo Nakao (21429026)

    Published 2025
    “…In session 2, only CH significantly decreased compared with the baseline. CH significantly decreases from the 20th heading onwards in session 1 compared with session 2 (both at 20 and 30 headings; p < 0.001). …”
  20. 19680

    Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics by Shan Li (110392)

    Published 2024
    “…Therapeutics for GIT disease treatment face multiple biological barriers, which significantly decrease the efficacy of therapeutics. …”